VIDEO: Lacrifill provides better dry eye management
Click Here to Manage Email Alerts
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Eric D. Donnenfeld, MD, discusses Lacrifill for the management of dry eye disease.
Donnenfeld called Lacrifill (Nordic Pharma), which launched May 29, the next generation of punctal occlusion.
“What makes it really special is that it’s not externally located, so you’re not going to have the irritation that you would have with an external plug,” he said. “It’s also not one-size-fits-all. It really binds to the inner wall of the canalicular structure, so it gives you better punctal occlusion than a regular punctal occluder.”
Reference:
- Nordic Group B.V. through its subsidiary Nordic Pharma, Inc. (U.S.), announces the launch of Lacrifill canalicular gel, a novel therapy for dry eye. https://www.nordicpharma.com/nordic-group-b-v-through-its-subsidiary-nordic-pharma-inc-u-s-announces-the-launch-of-lacrifill-canalicular-gel-a-novel-therapy-for-dry-eye/. Published May 29, 2024. Accessed May 31, 2024.